Comparison of Prehypertensive and Hypertensive Individuals

NCT06607328 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 109

Last updated 2024-09-23

No results posted yet for this study

Summary

Blood pressure is a physiological indicator that occurs due to the change in the pressure exerted by the blood in the vessel during the systole and diastole of the heart, which has similar results among people. Multiple pathophysiological mechanisms can be responsible for elevated blood pressure. In this change, hypertension is defined as conditions in which blood pressure rises above normal values and the pressure generated in the vessel wall can be measured as a numerical (quantitative) value. Many factors can affect arterial blood pressure, morbidity, and mortality rates such as activity limitation, activity performance level, kinesiophobia, quality of life, self-efficacy levels, physical activity, and comorbidity levels. According to our knowledge, there are almost no studies comparing prehypertensive and hypertensive individuals in the literature, so it is important to create appropriate treatment programs by taking precautions in the early period. Therefore, this study aimed to compare activity limitation, activity performance level, kinesiophobia, quality of life, self-efficacy levels, physical activity, and comorbidity levels of prehypertensive and hypertensive individuals.

Conditions

Interventions

OTHER

Assessment of participants in terms of different aspects.

This group was composed of individuals who have the prehypertensive stage.

Sponsors & Collaborators

  • Izmir Democracy University

    lead OTHER

Principal Investigators

  • FERRUH TAŞPINAR, Prof. Dr. · Izmir Democracy University

Eligibility

Min Age
22 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-07-01
Primary Completion
2023-06-01
Completion
2024-01-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06607328 on ClinicalTrials.gov